Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Austedo
Pharma
Hefty sales of generics boost Teva to another big quarter
Teva revealed booming third-quarter sales for its generics, with U.S. revenue from the knockoffs reaching $1.1 billion, which was a 30% increase.
Kevin Dunleavy
Nov 6, 2024 3:19pm
Teva rides growth momentum through Q2, boosts '24 sales outlook
Jul 31, 2024 9:11am
Teva CEO celebrates progress in 'Pivot to Growth' plan
May 8, 2024 3:02pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
BeiGene, BMS, AZ-FibroGen and more—Fierce Pharma Asia
Mar 1, 2024 8:55am
Teva rolls along in 2nd year of 'Pivot to Growth' strategy
Jan 31, 2024 3:06pm
